Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
20,250 | $34.5 | $698,625 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-10 Option Award |
2025-04-11 4:55 pm |
N/A 2035-04-09 |
Kalaris Therapeutics Inc. | KLRS | Oxtoby Andrew See Remarks |
287,000 | $0 | 287,000 (Direct) |
View |
2025-03-18 Option Award |
2025-03-18 5:41 pm |
N/A 2034-05-27 |
Kalaris Therapeutics Inc. | KLRS | Oxtoby Andrew See Remarks |
476,611 | $0 | 476,611 (Direct) |
View |
2023-02-28 Option Award |
2023-03-02 5:00 pm |
N/A 2033-02-27 |
CHINOOK THERAPEUTICS INC. | KDNY | Oxtoby Andrew Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
6,345 | $34.5 | 0 (Direct) |
View |
2020-09-15 Tax Withholding |
2020-09-16 5:19 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
840 | $34.25 | 26,595 (Direct) |
View |
2020-05-10 Option Award |
2020-05-12 5:20 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
2,420 | $0 | 27,435 (Direct) |
View |